Vitreoretinal diseases
Conditions
Interventions
1:perfluoronaphthalene (Suzhou Industrial Park JST Medical Equipment Co., LTD) used in surgery
2:perfluoronaphthalene (Bausch & Lomb) used in surgery
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or above, no gender limitation; 2. The investigator determined that perfluoronaphthalene should be used in ophthalmic surgery; 3. The subjects had vitreoretinal disease; 4. The subjects or their legal representatives can understand the purpose of the study and show sufficient compliance with the study protocol and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. The researcher determined that the candidate could not be selected; 2. The subjects who participate in the drug clinical trial or medical device clinical trial less than 1 month after the end or can not go to the hospital regularly for examination; 3. Patients with primary glaucoma; 4. Women during pregnancy and breast feeding; 5. Patients have important organ failure or other serious diseases, including clinically relevant cardiovascular and cerebrovascular diseases; History of severe optic nerve; Severe infection; Active disseminated intravascular coagulation; 6. Subjects with binocular retinopathy requiring simultaneous treatment with perfluoronaphthalene for ophthalmic surgery; 7. Patients suffering from mental illness hinder treatment and evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vital signs: blood pressure, heart rate, temperature;blood tests;residue or not;moves into the subretinal lumen or not;Lens condition;IOP; | — |
Secondary
| Measure | Time frame |
|---|---|
| anterior chamber; | — |
Countries
Chian
Contacts
Public ContactLu Peirong
the First Affiliated Hospital of Soochow University
Outcome results
None listed